A study of patients with metastatic lung cancer by researchers based in Brazil and the United States has found that their ...

Trinity College Dublin researchers based at St James's Hospital have provided important insights into the behavior and ...

A higher abundance of monocyte-derived alveolar macrophages significantly correlated with worse lung fibrosis in RPRA ...

Northwestern Medicine scientists have discovered how a protein in a deadly type of lung cancer can control how the immune ...

About 80% of people who have lung cancer have non-small-cell lung cancer. NSCLC usually spreads more slowly than small-cell lung cancers. Both cancers affect the lungs and have similar symptoms ...

FDA approves Optune Lua, a wearable device for metastatic NSCLC, offering a new treatment option after platinum-based ...

Genelux Corporation (NASDAQ: GNLX), a late-stage clinical immuno-oncology company, today announced that the first patient has been dosed in the U.S.-based Phase 2 (VIRO-25) trial evaluating ...

First targeted treatment to reduce the risk of ALK positive lung cancer returning after complete tumour removal recommended ...

Wearable device-based intervention was associated with overall improved physical activity and dyspnea after lung cancer ...

CAR T-cell therapy offers the "holy grail" of precision therapy in lung cancer, but it is biologically challenging and poses significant problems, according to experts.

The FDA has granted approval for Novocure‘s wearable medical device, Optune Lua, designed to treat advanced non-small cell ...

Photodynamic therapy: Doctors use light to kill cancer cells and shrink tumors. Stent: Lung tumors that have grown into an airway can cause trouble breathing or other problems. Your doctor puts a ...